The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells - PubMed (original) (raw)

. 2008 Oct 1;123(7):1545-50.

doi: 10.1002/ijc.23683.

Daniela Holland, Julia Bulkescher, Irena Crnković-Mertens, Karin Hoppe-Seyler, Hanswalter Zentgraf, Maria Pritsch, Stephan Buse, Jesco Pfitzenmaier, Axel Haferkamp, Markus Hohenfellner, Felix Hoppe-Seyler

Affiliations

• PMID: 18623083
• DOI: 10.1002/ijc.23683

The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells

Nina Wagener et al. Int J Cancer. 2008.

Abstract

The enhancer of zeste homolog 2 (EZH2) gene has been recently linked to human malignancies where it may serve as a new target for cancer therapy. Here, we analyzed EZH2 expression in primary renal cell carcinoma (RCC) specimens and in nontumorous tissue samples from adult kidney. EZH2 transcripts were detectable in all RCC specimens examined. Expression levels were significantly higher in tumor tissue (p < or = 0.0001) than in samples from normal adult kidney. Moreover, inhibition of endogenous EZH2 expression in RCC cell lines by RNA interference (RNAi) led to reduced proliferation and increased apoptosis in RCC cells. These data show that EZH2 is overexpressed in RCC. Furthermore, they indicate that the EZH2 gene plays a role for both the proliferation and the apoptosis resistance of RCC cells. Targeted inhibition of EZH2 could therefore represent a novel strategy to improve the therapeutic response of RCC.

PubMed Disclaimer

Similar articles

• MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
  Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ. Zhang JG, et al. J Thorac Oncol. 2011 Apr;6(4):671-8. doi: 10.1097/JTO.0b013e318208eb35. J Thorac Oncol. 2011. PMID: 21270667
• Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.
  Liu L, Xu Z, Zhong L, Wang H, Jiang S, Long Q, Xu J, Guo J. Liu L, et al. BJU Int. 2016 Feb;117(2):351-62. doi: 10.1111/bju.12702. Epub 2015 Apr 21. BJU Int. 2016. PMID: 24612432
• Enhancer of zeste homolog 2 expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma: a comparative study and review of the literature.
  Xu B, Abourbih S, Sircar K, Kassouf W, Mansure JJ, Aprikian A, Tanguay S, Brimo F. Xu B, et al. Arch Pathol Lab Med. 2013 Oct;137(10):1326-36. doi: 10.5858/arpa.2012-0525-OA. Arch Pathol Lab Med. 2013. PMID: 24079759 Review.
• [Recent advances on EZH2 in malignant tumors].
  Li J, Fan QH. Li J, et al. Zhonghua Bing Li Xue Za Zhi. 2009 Dec;38(12):856-8. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 20193471 Review. Chinese. No abstract available.

Cited by

• Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targets.
  Dondeti VR, Wubbenhorst B, Lal P, Gordan JD, D'Andrea K, Attiyeh EF, Simon MC, Nathanson KL. Dondeti VR, et al. Cancer Res. 2012 Jan 1;72(1):112-21. doi: 10.1158/0008-5472.CAN-11-1698. Epub 2011 Nov 17. Cancer Res. 2012. PMID: 22094876 Free PMC article.
• EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma.
  Xu S, Ma B, Feng X, Yao C, Jian Y, Chen Y, Wang X, Xie H, Li L. Xu S, et al. Transl Androl Urol. 2023 Jan 30;12(1):71-82. doi: 10.21037/tau-22-817. Epub 2023 Jan 1. Transl Androl Urol. 2023. PMID: 36760869 Free PMC article.
• Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.
  Basheer F, Giotopoulos G, Meduri E, Yun H, Mazan M, Sasca D, Gallipoli P, Marando L, Gozdecka M, Asby R, Sheppard O, Dudek M, Bullinger L, Döhner H, Dillon R, Freeman S, Ottmann O, Burnett A, Russell N, Papaemmanuil E, Hills R, Campbell P, Vassiliou GS, Huntly BJP. Basheer F, et al. J Exp Med. 2019 Apr 1;216(4):966-981. doi: 10.1084/jem.20181276. Epub 2019 Mar 19. J Exp Med. 2019. PMID: 30890554 Free PMC article.
• The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma.
  Rysz J, Konecki T, Franczyk B, Ławiński J, Gluba-Brzózka A. Rysz J, et al. Int J Mol Sci. 2022 Dec 30;24(1):643. doi: 10.3390/ijms24010643. Int J Mol Sci. 2022. PMID: 36614082 Free PMC article. Review.
• Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.
  Zhang Q, Padi SK, Tindall DJ, Guo B. Zhang Q, et al. Cell Death Dis. 2014 Oct 23;5(10):e1486. doi: 10.1038/cddis.2014.454. Cell Death Dis. 2014. PMID: 25341040 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information